Getting your genetic test results

  • Getting the results of a genetic test is likely to be an emotional time

  • You may feel shocked and upset if you have inherited a faulty gene

  • Your doctor might recommend regular screening or treatment to reduce your risk of developing cancer

Genetic testing can tell you whether you have inherited a faulty gene that increases your risk of developing cancer.


What if the test doesn’t find a faulty gene?

A negative test result means that you are not carrying the faulty gene. This doesn’t mean that you definitely won’t get cancer. Your risk is the same as everyone else. You can still reduce your risk by choosing a healthy lifestyle.

You could still be at high risk of particular cancers even if you have a negative result. Genetic testing usually only looks for faults in the known high risk genes. The uncertainty of this can be very difficult to deal with. Your genetics counsellor will advise and support you.


What if the test does find a faulty gene?

A positive test result means that you are carrying the faulty gene. This doesn’t mean that you have or will definitely develop cancer. But your risk is higher than the general population.

It can be difficult to find out that you have an increased risk of developing cancer. Most people who have a positive result will feel a range of emotions such as:

  • resentment
  • anger
  • worry
  • anxiety

This is understandable. Some people find that it helps to talk to their family members about their feelings. Other people may prefer to talk to a counsellor.

You can talk to your doctor or genetic counsellor to find out how much your risk of cancer is increased. They can tell you what check ups you need and how often you will need to have them. It is important to remember that not everyone who has a faulty gene goes on to develop cancer.

Whatever your situation, you can help to reduce your risk by choosing a healthy lifestyle.


Telling your relatives

You may be worried about which family members to tell and how to tell them. Your genetic counsellor can help you work out the best way to do this. Some clinics have prepared letters that you can send out to relatives but you may prefer to tell people face to face. Or you might want to do a mix of both, depending on which relative it is and your relationship with them.

Your relatives’ reactions may vary. It may be a shock to them if they hadn’t thought about having a family history of cancer. Some people may choose to ignore the result and may even find it difficult to talk to you afterwards. Others will be glad that you have warned them about the possibility that they may have a faulty gene and will then want to have a test themselves.

You might get test results at the same time as other family members. This can be very hard to cope with. You might feel guilty if you do not have a faulty gene, but your relatives do. You might also be trying to cope with their results. 

Talking together as a family might be helpful. You can talk together at the genetic clinic, or with a counsellor. You could also try individual counselling. You can go back again if you don’t want counselling straight away. 


Your options if you have an increased risk of cancer

Depending on the type of faulty gene and the types of cancer you are at risk of developing, your doctor might recommend:

  • regular screening
  • treatments such as surgery or medicines


Regular screening to detect cancer early

Screening aims to spot cancers at an early stage when treatment is more likely to be successful. It can also help prevent cancer from developing by looking for changes that could lead to cancer.

The type of screening you have, when it starts, and how often you have it will depend on the type of cancer you are at risk of getting.

We have more information about screening for people at high risk of particular cancers:


Treatment to reduce your risk of developing cancer

You may be able to have treatment to reduce your risk of getting cancer. This might include surgery or medicines to reduce cancer risk. This is possible for some types of cancer where there is a known faulty gene.

When you have risk reducing treatments depends on the type of cancer you are at risk of developing, and the type of faulty gene. For some cancers, your risk may not be significantly increased until you are in your 40's. For other types of cancer, you might need treatment earlier. 


Surgery to reduce cancer risk

The main risk reducing treatment is surgery to remove the part of the body at risk of developing cancer. Risk reducing surgery doesn’t necessarily stop you from getting cancer completely. Nobody can guarantee that. But it will significantly reduce your risk of getting a particular type of cancer.

Surgery can change how you feel about yourself. For some people, knowing that they have reduced their risk makes them feel more confident and happier. For others, the changes in their body, whether visible or not, are very difficult to cope with. It is important to try to think about how you will feel if you do have treatment and how you may feel if you don’t.

Talk to your genetics specialist about the risks and benefits of having risk reducing surgery.  

Breast or ovarian cancer
Women who have a high risk of developing breast or ovarian cancer may choose to have both breasts removed with breast reconstruction. This is called preventive mastectomy, risk reducing breast surgery, or prophylactic mastectomy. They may also choose to have their ovaries and fallopian tubes removed. This is called prophylactic salpingo-oophorectomy or risk reducing ovarian surgery.

Bowel cancer
You may be able to have an operation to remove your large bowel to reduce your risk of bowel cancer. This is called prophylactic colectomy.  

Thyroid cancer
Your doctor may suggest you have surgery to remove your thyroid if you have inherited a faulty gene. This is called prophylactic thyroidectomy.


Medicines to reduce cancer risk

You may choose to take medicines instead of having surgery if you have an increased risk of developing breast cancer. This is called chemoprevention. You usually have a drug called tamoxifen or raloxifene.

People diagnosed with Lynch syndrome can take aspirin to reduce the risk of developing cancer.

Find out about taking medicines to lower your risk of developing breast cancer.


Deciding whether to have risk reducing treatment

Choosing to have treatment to reduce your risk of cancer is a very personal decision. Before you decide to have any treatment to reduce your risk, it is worth thinking about the following questions:

  • what treatment options are available to you?
  • how much will treatment reduce your risk of developing cancer?
  • how do you feel about having treatment?
  • what does the treatment involve?
  • what are the immediate and long term side effects of treatment?
  • can side effects be controlled?
  • when should you have treatment?
  • will the treatment affect your fertility?
  • can you time your preventative treatment so that you can have a family first?

Finding out that you have a gene fault may make you think about the choices you make in your life. For example:

  • you may decide to have children earlier than you had planned, before having your ovaries removed
  • you may want to have tests before pregnancy to avoid passing on a faulty gene
  • it may affect the choices you make about work and your career

Your genetic counsellor or specialist nurse can talk through your options and help you decide what is right for you.

  • Cancer: Principles & Practice of Oncology (10th edition)
    VT DeVita, TS Lawrence and SA Rosenberg
    Lippincott, Williams and Wilkins, 2015

  • Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
    British Society of Gastroenterology, 2020

  • Breast screening for women with a high risk of breast cancer
    Public Health England, Updated April 2021

  • Management of women with a genetic predisposition to gynaecological cancers (scientific impact paper no 48)
    Royal College of Obstetricians & Gynaecologists, February 2015

  • Ovarian cancer population screening and mortality after long-term follow up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial
    U Menon and others
    The Lancet, 2021. Vol 397, Issue 10290, Pages 2182-2193

The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. Please contact with details of the particular issue you are interested in if you need additional references for this information.

Last reviewed

Rate this page:

Currently rated: 2.8 out of 5 based on 36 votes
Thank you!
We've recently made some changes to the site, tell us what you think